PMID- 28493811
OWN - NLM
STAT- MEDLINE
DCOM- 20170915
LR  - 20220316
IS  - 1527-7755 (Electronic)
IS  - 0732-183X (Print)
IS  - 0732-183X (Linking)
VI  - 35
IP  - 25
DP  - 2017 Sep 1
TI  - Pooled Analysis of Individual Patient Data on Concurrent Chemoradiotherapy for 
      Stage III Non-Small-Cell Lung Cancer in Elderly Patients Compared With Younger 
      Patients Who Participated in US National Cancer Institute Cooperative Group 
      Studies.
PG  - 2885-2892
LID - 10.1200/JCO.2016.71.4758 [doi]
AB  - Purpose Concurrent chemoradiotherapy is standard treatment for patients with 
      stage III non-small-cell lung cancer. Elderly patients may experience increased 
      rates of adverse events (AEs) or less benefit from concurrent chemoradiotherapy. 
      Patients and Methods Individual patient data were collected from 16 phase II or 
      III trials conducted by US National Cancer Institute-supported cooperative groups 
      of concurrent chemoradiotherapy alone or with consolidation or induction 
      chemotherapy for stage III non-small-cell lung cancer from 1990 to 2012. Overall 
      survival (OS), progression-free survival, and AEs were compared between patients 
      age >/= 70 (elderly) and those younger than 70 years (younger). Unadjusted and 
      adjusted hazard ratios (HRs) for survival time and CIs were estimated by 
      single-predictor and multivariable frailty Cox models. Unadjusted and adjusted 
      odds ratio (ORs) for AEs and CIs were obtained from single-predictor and 
      multivariable generalized linear mixed-effect models. Results A total of 2,768 
      patients were classified as younger and 832 as elderly. In unadjusted and 
      multivariable models, elderly patients had worse OS (HR, 1.20; 95% CI, 1.09 to 
      1.31 and HR, 1.17; 95% CI, 1.07 to 1.29, respectively). In unadjusted and 
      multivariable models, elderly and younger patients had similar progression-free 
      survival (HR, 1.01; 95% CI, 0.93 to 1.10 and HR, 1.00; 95% CI, 0.91 to 1.09, 
      respectively). Elderly patients had a higher rate of grade >/= 3 AEs in unadjusted 
      and multivariable models (OR, 1.35; 95% CI, 1.07 to 1.70 and OR, 1.38; 95% CI, 
      1.10 to 1.74, respectively). Grade 5 AEs were significantly higher in elderly 
      compared with younger patients (9% v 4%; P < .01). Fewer elderly compared with 
      younger patients completed treatment (47% v 57%; P < .01), and more discontinued 
      treatment because of AEs (20% v 13%; P < .01), died during treatment (7.8% v 
      2.9%; P < .01), and refused further treatment (5.8% v 3.9%; P = .02). Conclusion 
      Elderly patients in concurrent chemoradiotherapy trials experienced worse OS, 
      more toxicity, and had a higher rate of death during treatment than younger 
      patients.
FAU - Stinchcombe, Thomas E
AU  - Stinchcombe TE
AD  - Thomas E. Stinchcombe, Neal E. Ready, and Harvey J. Cohen, Duke University 
      Medical Center; Xiaofei Wang, Alliance Statistics and Data Center, Durham, NC; 
      Ying Zhang, Pennsylvania State University College of Medicine, Hershey, PA; 
      Everett E. Vokes, University of Chicago Medical Center, Chicago, IL; Joan H. 
      Schiller, Inova Dwight and Martha Schar Cancer Institute, Falls Church, VA; 
      Jeffrey D. Bradley and Ramaswamy Govindan, Washington University School of 
      Medicine, St Louis, MO; Karen Kelly, University of California Davis, Sacramento, 
      CA; Walter J. Curran Jr, Winship Cancer Institute of Emory University, Atlanta, 
      GA; Steven E. Schild, Mayo Clinic Arizona, Scottsdale, AZ; Benjamin Movsas, Henry 
      Ford Health System, Detroit, MI; Gerald Clamon, University of Iowa Hospital and 
      Clinics, Iowa City, IA; George R. Blumenschein, University of Texas MD Anderson 
      Cancer Center, Houston, TX; Mark A. Socinski, Florida Hospital Cancer Institute, 
      Orlando, FL; Wallace L. Akerley, Huntsman Cancer Institute, University of Utah, 
      Salt Lake City, UT; and Herbert H. Pang, University of Hong Kong, Hong Kong 
      Special Administrative Region, People's Republic of China.
FAU - Zhang, Ying
AU  - Zhang Y
AD  - Thomas E. Stinchcombe, Neal E. Ready, and Harvey J. Cohen, Duke University 
      Medical Center; Xiaofei Wang, Alliance Statistics and Data Center, Durham, NC; 
      Ying Zhang, Pennsylvania State University College of Medicine, Hershey, PA; 
      Everett E. Vokes, University of Chicago Medical Center, Chicago, IL; Joan H. 
      Schiller, Inova Dwight and Martha Schar Cancer Institute, Falls Church, VA; 
      Jeffrey D. Bradley and Ramaswamy Govindan, Washington University School of 
      Medicine, St Louis, MO; Karen Kelly, University of California Davis, Sacramento, 
      CA; Walter J. Curran Jr, Winship Cancer Institute of Emory University, Atlanta, 
      GA; Steven E. Schild, Mayo Clinic Arizona, Scottsdale, AZ; Benjamin Movsas, Henry 
      Ford Health System, Detroit, MI; Gerald Clamon, University of Iowa Hospital and 
      Clinics, Iowa City, IA; George R. Blumenschein, University of Texas MD Anderson 
      Cancer Center, Houston, TX; Mark A. Socinski, Florida Hospital Cancer Institute, 
      Orlando, FL; Wallace L. Akerley, Huntsman Cancer Institute, University of Utah, 
      Salt Lake City, UT; and Herbert H. Pang, University of Hong Kong, Hong Kong 
      Special Administrative Region, People's Republic of China.
FAU - Vokes, Everett E
AU  - Vokes EE
AD  - Thomas E. Stinchcombe, Neal E. Ready, and Harvey J. Cohen, Duke University 
      Medical Center; Xiaofei Wang, Alliance Statistics and Data Center, Durham, NC; 
      Ying Zhang, Pennsylvania State University College of Medicine, Hershey, PA; 
      Everett E. Vokes, University of Chicago Medical Center, Chicago, IL; Joan H. 
      Schiller, Inova Dwight and Martha Schar Cancer Institute, Falls Church, VA; 
      Jeffrey D. Bradley and Ramaswamy Govindan, Washington University School of 
      Medicine, St Louis, MO; Karen Kelly, University of California Davis, Sacramento, 
      CA; Walter J. Curran Jr, Winship Cancer Institute of Emory University, Atlanta, 
      GA; Steven E. Schild, Mayo Clinic Arizona, Scottsdale, AZ; Benjamin Movsas, Henry 
      Ford Health System, Detroit, MI; Gerald Clamon, University of Iowa Hospital and 
      Clinics, Iowa City, IA; George R. Blumenschein, University of Texas MD Anderson 
      Cancer Center, Houston, TX; Mark A. Socinski, Florida Hospital Cancer Institute, 
      Orlando, FL; Wallace L. Akerley, Huntsman Cancer Institute, University of Utah, 
      Salt Lake City, UT; and Herbert H. Pang, University of Hong Kong, Hong Kong 
      Special Administrative Region, People's Republic of China.
FAU - Schiller, Joan H
AU  - Schiller JH
AD  - Thomas E. Stinchcombe, Neal E. Ready, and Harvey J. Cohen, Duke University 
      Medical Center; Xiaofei Wang, Alliance Statistics and Data Center, Durham, NC; 
      Ying Zhang, Pennsylvania State University College of Medicine, Hershey, PA; 
      Everett E. Vokes, University of Chicago Medical Center, Chicago, IL; Joan H. 
      Schiller, Inova Dwight and Martha Schar Cancer Institute, Falls Church, VA; 
      Jeffrey D. Bradley and Ramaswamy Govindan, Washington University School of 
      Medicine, St Louis, MO; Karen Kelly, University of California Davis, Sacramento, 
      CA; Walter J. Curran Jr, Winship Cancer Institute of Emory University, Atlanta, 
      GA; Steven E. Schild, Mayo Clinic Arizona, Scottsdale, AZ; Benjamin Movsas, Henry 
      Ford Health System, Detroit, MI; Gerald Clamon, University of Iowa Hospital and 
      Clinics, Iowa City, IA; George R. Blumenschein, University of Texas MD Anderson 
      Cancer Center, Houston, TX; Mark A. Socinski, Florida Hospital Cancer Institute, 
      Orlando, FL; Wallace L. Akerley, Huntsman Cancer Institute, University of Utah, 
      Salt Lake City, UT; and Herbert H. Pang, University of Hong Kong, Hong Kong 
      Special Administrative Region, People's Republic of China.
FAU - Bradley, Jeffrey D
AU  - Bradley JD
AD  - Thomas E. Stinchcombe, Neal E. Ready, and Harvey J. Cohen, Duke University 
      Medical Center; Xiaofei Wang, Alliance Statistics and Data Center, Durham, NC; 
      Ying Zhang, Pennsylvania State University College of Medicine, Hershey, PA; 
      Everett E. Vokes, University of Chicago Medical Center, Chicago, IL; Joan H. 
      Schiller, Inova Dwight and Martha Schar Cancer Institute, Falls Church, VA; 
      Jeffrey D. Bradley and Ramaswamy Govindan, Washington University School of 
      Medicine, St Louis, MO; Karen Kelly, University of California Davis, Sacramento, 
      CA; Walter J. Curran Jr, Winship Cancer Institute of Emory University, Atlanta, 
      GA; Steven E. Schild, Mayo Clinic Arizona, Scottsdale, AZ; Benjamin Movsas, Henry 
      Ford Health System, Detroit, MI; Gerald Clamon, University of Iowa Hospital and 
      Clinics, Iowa City, IA; George R. Blumenschein, University of Texas MD Anderson 
      Cancer Center, Houston, TX; Mark A. Socinski, Florida Hospital Cancer Institute, 
      Orlando, FL; Wallace L. Akerley, Huntsman Cancer Institute, University of Utah, 
      Salt Lake City, UT; and Herbert H. Pang, University of Hong Kong, Hong Kong 
      Special Administrative Region, People's Republic of China.
FAU - Kelly, Karen
AU  - Kelly K
AD  - Thomas E. Stinchcombe, Neal E. Ready, and Harvey J. Cohen, Duke University 
      Medical Center; Xiaofei Wang, Alliance Statistics and Data Center, Durham, NC; 
      Ying Zhang, Pennsylvania State University College of Medicine, Hershey, PA; 
      Everett E. Vokes, University of Chicago Medical Center, Chicago, IL; Joan H. 
      Schiller, Inova Dwight and Martha Schar Cancer Institute, Falls Church, VA; 
      Jeffrey D. Bradley and Ramaswamy Govindan, Washington University School of 
      Medicine, St Louis, MO; Karen Kelly, University of California Davis, Sacramento, 
      CA; Walter J. Curran Jr, Winship Cancer Institute of Emory University, Atlanta, 
      GA; Steven E. Schild, Mayo Clinic Arizona, Scottsdale, AZ; Benjamin Movsas, Henry 
      Ford Health System, Detroit, MI; Gerald Clamon, University of Iowa Hospital and 
      Clinics, Iowa City, IA; George R. Blumenschein, University of Texas MD Anderson 
      Cancer Center, Houston, TX; Mark A. Socinski, Florida Hospital Cancer Institute, 
      Orlando, FL; Wallace L. Akerley, Huntsman Cancer Institute, University of Utah, 
      Salt Lake City, UT; and Herbert H. Pang, University of Hong Kong, Hong Kong 
      Special Administrative Region, People's Republic of China.
FAU - Curran, Walter J Jr
AU  - Curran WJ Jr
AD  - Thomas E. Stinchcombe, Neal E. Ready, and Harvey J. Cohen, Duke University 
      Medical Center; Xiaofei Wang, Alliance Statistics and Data Center, Durham, NC; 
      Ying Zhang, Pennsylvania State University College of Medicine, Hershey, PA; 
      Everett E. Vokes, University of Chicago Medical Center, Chicago, IL; Joan H. 
      Schiller, Inova Dwight and Martha Schar Cancer Institute, Falls Church, VA; 
      Jeffrey D. Bradley and Ramaswamy Govindan, Washington University School of 
      Medicine, St Louis, MO; Karen Kelly, University of California Davis, Sacramento, 
      CA; Walter J. Curran Jr, Winship Cancer Institute of Emory University, Atlanta, 
      GA; Steven E. Schild, Mayo Clinic Arizona, Scottsdale, AZ; Benjamin Movsas, Henry 
      Ford Health System, Detroit, MI; Gerald Clamon, University of Iowa Hospital and 
      Clinics, Iowa City, IA; George R. Blumenschein, University of Texas MD Anderson 
      Cancer Center, Houston, TX; Mark A. Socinski, Florida Hospital Cancer Institute, 
      Orlando, FL; Wallace L. Akerley, Huntsman Cancer Institute, University of Utah, 
      Salt Lake City, UT; and Herbert H. Pang, University of Hong Kong, Hong Kong 
      Special Administrative Region, People's Republic of China.
FAU - Schild, Steven E
AU  - Schild SE
AD  - Thomas E. Stinchcombe, Neal E. Ready, and Harvey J. Cohen, Duke University 
      Medical Center; Xiaofei Wang, Alliance Statistics and Data Center, Durham, NC; 
      Ying Zhang, Pennsylvania State University College of Medicine, Hershey, PA; 
      Everett E. Vokes, University of Chicago Medical Center, Chicago, IL; Joan H. 
      Schiller, Inova Dwight and Martha Schar Cancer Institute, Falls Church, VA; 
      Jeffrey D. Bradley and Ramaswamy Govindan, Washington University School of 
      Medicine, St Louis, MO; Karen Kelly, University of California Davis, Sacramento, 
      CA; Walter J. Curran Jr, Winship Cancer Institute of Emory University, Atlanta, 
      GA; Steven E. Schild, Mayo Clinic Arizona, Scottsdale, AZ; Benjamin Movsas, Henry 
      Ford Health System, Detroit, MI; Gerald Clamon, University of Iowa Hospital and 
      Clinics, Iowa City, IA; George R. Blumenschein, University of Texas MD Anderson 
      Cancer Center, Houston, TX; Mark A. Socinski, Florida Hospital Cancer Institute, 
      Orlando, FL; Wallace L. Akerley, Huntsman Cancer Institute, University of Utah, 
      Salt Lake City, UT; and Herbert H. Pang, University of Hong Kong, Hong Kong 
      Special Administrative Region, People's Republic of China.
FAU - Movsas, Benjamin
AU  - Movsas B
AD  - Thomas E. Stinchcombe, Neal E. Ready, and Harvey J. Cohen, Duke University 
      Medical Center; Xiaofei Wang, Alliance Statistics and Data Center, Durham, NC; 
      Ying Zhang, Pennsylvania State University College of Medicine, Hershey, PA; 
      Everett E. Vokes, University of Chicago Medical Center, Chicago, IL; Joan H. 
      Schiller, Inova Dwight and Martha Schar Cancer Institute, Falls Church, VA; 
      Jeffrey D. Bradley and Ramaswamy Govindan, Washington University School of 
      Medicine, St Louis, MO; Karen Kelly, University of California Davis, Sacramento, 
      CA; Walter J. Curran Jr, Winship Cancer Institute of Emory University, Atlanta, 
      GA; Steven E. Schild, Mayo Clinic Arizona, Scottsdale, AZ; Benjamin Movsas, Henry 
      Ford Health System, Detroit, MI; Gerald Clamon, University of Iowa Hospital and 
      Clinics, Iowa City, IA; George R. Blumenschein, University of Texas MD Anderson 
      Cancer Center, Houston, TX; Mark A. Socinski, Florida Hospital Cancer Institute, 
      Orlando, FL; Wallace L. Akerley, Huntsman Cancer Institute, University of Utah, 
      Salt Lake City, UT; and Herbert H. Pang, University of Hong Kong, Hong Kong 
      Special Administrative Region, People's Republic of China.
FAU - Clamon, Gerald
AU  - Clamon G
AD  - Thomas E. Stinchcombe, Neal E. Ready, and Harvey J. Cohen, Duke University 
      Medical Center; Xiaofei Wang, Alliance Statistics and Data Center, Durham, NC; 
      Ying Zhang, Pennsylvania State University College of Medicine, Hershey, PA; 
      Everett E. Vokes, University of Chicago Medical Center, Chicago, IL; Joan H. 
      Schiller, Inova Dwight and Martha Schar Cancer Institute, Falls Church, VA; 
      Jeffrey D. Bradley and Ramaswamy Govindan, Washington University School of 
      Medicine, St Louis, MO; Karen Kelly, University of California Davis, Sacramento, 
      CA; Walter J. Curran Jr, Winship Cancer Institute of Emory University, Atlanta, 
      GA; Steven E. Schild, Mayo Clinic Arizona, Scottsdale, AZ; Benjamin Movsas, Henry 
      Ford Health System, Detroit, MI; Gerald Clamon, University of Iowa Hospital and 
      Clinics, Iowa City, IA; George R. Blumenschein, University of Texas MD Anderson 
      Cancer Center, Houston, TX; Mark A. Socinski, Florida Hospital Cancer Institute, 
      Orlando, FL; Wallace L. Akerley, Huntsman Cancer Institute, University of Utah, 
      Salt Lake City, UT; and Herbert H. Pang, University of Hong Kong, Hong Kong 
      Special Administrative Region, People's Republic of China.
FAU - Govindan, Ramaswamy
AU  - Govindan R
AD  - Thomas E. Stinchcombe, Neal E. Ready, and Harvey J. Cohen, Duke University 
      Medical Center; Xiaofei Wang, Alliance Statistics and Data Center, Durham, NC; 
      Ying Zhang, Pennsylvania State University College of Medicine, Hershey, PA; 
      Everett E. Vokes, University of Chicago Medical Center, Chicago, IL; Joan H. 
      Schiller, Inova Dwight and Martha Schar Cancer Institute, Falls Church, VA; 
      Jeffrey D. Bradley and Ramaswamy Govindan, Washington University School of 
      Medicine, St Louis, MO; Karen Kelly, University of California Davis, Sacramento, 
      CA; Walter J. Curran Jr, Winship Cancer Institute of Emory University, Atlanta, 
      GA; Steven E. Schild, Mayo Clinic Arizona, Scottsdale, AZ; Benjamin Movsas, Henry 
      Ford Health System, Detroit, MI; Gerald Clamon, University of Iowa Hospital and 
      Clinics, Iowa City, IA; George R. Blumenschein, University of Texas MD Anderson 
      Cancer Center, Houston, TX; Mark A. Socinski, Florida Hospital Cancer Institute, 
      Orlando, FL; Wallace L. Akerley, Huntsman Cancer Institute, University of Utah, 
      Salt Lake City, UT; and Herbert H. Pang, University of Hong Kong, Hong Kong 
      Special Administrative Region, People's Republic of China.
FAU - Blumenschein, George R
AU  - Blumenschein GR
AD  - Thomas E. Stinchcombe, Neal E. Ready, and Harvey J. Cohen, Duke University 
      Medical Center; Xiaofei Wang, Alliance Statistics and Data Center, Durham, NC; 
      Ying Zhang, Pennsylvania State University College of Medicine, Hershey, PA; 
      Everett E. Vokes, University of Chicago Medical Center, Chicago, IL; Joan H. 
      Schiller, Inova Dwight and Martha Schar Cancer Institute, Falls Church, VA; 
      Jeffrey D. Bradley and Ramaswamy Govindan, Washington University School of 
      Medicine, St Louis, MO; Karen Kelly, University of California Davis, Sacramento, 
      CA; Walter J. Curran Jr, Winship Cancer Institute of Emory University, Atlanta, 
      GA; Steven E. Schild, Mayo Clinic Arizona, Scottsdale, AZ; Benjamin Movsas, Henry 
      Ford Health System, Detroit, MI; Gerald Clamon, University of Iowa Hospital and 
      Clinics, Iowa City, IA; George R. Blumenschein, University of Texas MD Anderson 
      Cancer Center, Houston, TX; Mark A. Socinski, Florida Hospital Cancer Institute, 
      Orlando, FL; Wallace L. Akerley, Huntsman Cancer Institute, University of Utah, 
      Salt Lake City, UT; and Herbert H. Pang, University of Hong Kong, Hong Kong 
      Special Administrative Region, People's Republic of China.
FAU - Socinski, Mark A
AU  - Socinski MA
AD  - Thomas E. Stinchcombe, Neal E. Ready, and Harvey J. Cohen, Duke University 
      Medical Center; Xiaofei Wang, Alliance Statistics and Data Center, Durham, NC; 
      Ying Zhang, Pennsylvania State University College of Medicine, Hershey, PA; 
      Everett E. Vokes, University of Chicago Medical Center, Chicago, IL; Joan H. 
      Schiller, Inova Dwight and Martha Schar Cancer Institute, Falls Church, VA; 
      Jeffrey D. Bradley and Ramaswamy Govindan, Washington University School of 
      Medicine, St Louis, MO; Karen Kelly, University of California Davis, Sacramento, 
      CA; Walter J. Curran Jr, Winship Cancer Institute of Emory University, Atlanta, 
      GA; Steven E. Schild, Mayo Clinic Arizona, Scottsdale, AZ; Benjamin Movsas, Henry 
      Ford Health System, Detroit, MI; Gerald Clamon, University of Iowa Hospital and 
      Clinics, Iowa City, IA; George R. Blumenschein, University of Texas MD Anderson 
      Cancer Center, Houston, TX; Mark A. Socinski, Florida Hospital Cancer Institute, 
      Orlando, FL; Wallace L. Akerley, Huntsman Cancer Institute, University of Utah, 
      Salt Lake City, UT; and Herbert H. Pang, University of Hong Kong, Hong Kong 
      Special Administrative Region, People's Republic of China.
FAU - Ready, Neal E
AU  - Ready NE
AD  - Thomas E. Stinchcombe, Neal E. Ready, and Harvey J. Cohen, Duke University 
      Medical Center; Xiaofei Wang, Alliance Statistics and Data Center, Durham, NC; 
      Ying Zhang, Pennsylvania State University College of Medicine, Hershey, PA; 
      Everett E. Vokes, University of Chicago Medical Center, Chicago, IL; Joan H. 
      Schiller, Inova Dwight and Martha Schar Cancer Institute, Falls Church, VA; 
      Jeffrey D. Bradley and Ramaswamy Govindan, Washington University School of 
      Medicine, St Louis, MO; Karen Kelly, University of California Davis, Sacramento, 
      CA; Walter J. Curran Jr, Winship Cancer Institute of Emory University, Atlanta, 
      GA; Steven E. Schild, Mayo Clinic Arizona, Scottsdale, AZ; Benjamin Movsas, Henry 
      Ford Health System, Detroit, MI; Gerald Clamon, University of Iowa Hospital and 
      Clinics, Iowa City, IA; George R. Blumenschein, University of Texas MD Anderson 
      Cancer Center, Houston, TX; Mark A. Socinski, Florida Hospital Cancer Institute, 
      Orlando, FL; Wallace L. Akerley, Huntsman Cancer Institute, University of Utah, 
      Salt Lake City, UT; and Herbert H. Pang, University of Hong Kong, Hong Kong 
      Special Administrative Region, People's Republic of China.
FAU - Akerley, Wallace L
AU  - Akerley WL
AD  - Thomas E. Stinchcombe, Neal E. Ready, and Harvey J. Cohen, Duke University 
      Medical Center; Xiaofei Wang, Alliance Statistics and Data Center, Durham, NC; 
      Ying Zhang, Pennsylvania State University College of Medicine, Hershey, PA; 
      Everett E. Vokes, University of Chicago Medical Center, Chicago, IL; Joan H. 
      Schiller, Inova Dwight and Martha Schar Cancer Institute, Falls Church, VA; 
      Jeffrey D. Bradley and Ramaswamy Govindan, Washington University School of 
      Medicine, St Louis, MO; Karen Kelly, University of California Davis, Sacramento, 
      CA; Walter J. Curran Jr, Winship Cancer Institute of Emory University, Atlanta, 
      GA; Steven E. Schild, Mayo Clinic Arizona, Scottsdale, AZ; Benjamin Movsas, Henry 
      Ford Health System, Detroit, MI; Gerald Clamon, University of Iowa Hospital and 
      Clinics, Iowa City, IA; George R. Blumenschein, University of Texas MD Anderson 
      Cancer Center, Houston, TX; Mark A. Socinski, Florida Hospital Cancer Institute, 
      Orlando, FL; Wallace L. Akerley, Huntsman Cancer Institute, University of Utah, 
      Salt Lake City, UT; and Herbert H. Pang, University of Hong Kong, Hong Kong 
      Special Administrative Region, People's Republic of China.
FAU - Cohen, Harvey J
AU  - Cohen HJ
AD  - Thomas E. Stinchcombe, Neal E. Ready, and Harvey J. Cohen, Duke University 
      Medical Center; Xiaofei Wang, Alliance Statistics and Data Center, Durham, NC; 
      Ying Zhang, Pennsylvania State University College of Medicine, Hershey, PA; 
      Everett E. Vokes, University of Chicago Medical Center, Chicago, IL; Joan H. 
      Schiller, Inova Dwight and Martha Schar Cancer Institute, Falls Church, VA; 
      Jeffrey D. Bradley and Ramaswamy Govindan, Washington University School of 
      Medicine, St Louis, MO; Karen Kelly, University of California Davis, Sacramento, 
      CA; Walter J. Curran Jr, Winship Cancer Institute of Emory University, Atlanta, 
      GA; Steven E. Schild, Mayo Clinic Arizona, Scottsdale, AZ; Benjamin Movsas, Henry 
      Ford Health System, Detroit, MI; Gerald Clamon, University of Iowa Hospital and 
      Clinics, Iowa City, IA; George R. Blumenschein, University of Texas MD Anderson 
      Cancer Center, Houston, TX; Mark A. Socinski, Florida Hospital Cancer Institute, 
      Orlando, FL; Wallace L. Akerley, Huntsman Cancer Institute, University of Utah, 
      Salt Lake City, UT; and Herbert H. Pang, University of Hong Kong, Hong Kong 
      Special Administrative Region, People's Republic of China.
FAU - Pang, Herbert H
AU  - Pang HH
AD  - Thomas E. Stinchcombe, Neal E. Ready, and Harvey J. Cohen, Duke University 
      Medical Center; Xiaofei Wang, Alliance Statistics and Data Center, Durham, NC; 
      Ying Zhang, Pennsylvania State University College of Medicine, Hershey, PA; 
      Everett E. Vokes, University of Chicago Medical Center, Chicago, IL; Joan H. 
      Schiller, Inova Dwight and Martha Schar Cancer Institute, Falls Church, VA; 
      Jeffrey D. Bradley and Ramaswamy Govindan, Washington University School of 
      Medicine, St Louis, MO; Karen Kelly, University of California Davis, Sacramento, 
      CA; Walter J. Curran Jr, Winship Cancer Institute of Emory University, Atlanta, 
      GA; Steven E. Schild, Mayo Clinic Arizona, Scottsdale, AZ; Benjamin Movsas, Henry 
      Ford Health System, Detroit, MI; Gerald Clamon, University of Iowa Hospital and 
      Clinics, Iowa City, IA; George R. Blumenschein, University of Texas MD Anderson 
      Cancer Center, Houston, TX; Mark A. Socinski, Florida Hospital Cancer Institute, 
      Orlando, FL; Wallace L. Akerley, Huntsman Cancer Institute, University of Utah, 
      Salt Lake City, UT; and Herbert H. Pang, University of Hong Kong, Hong Kong 
      Special Administrative Region, People's Republic of China.
FAU - Wang, Xiaofei
AU  - Wang X
AD  - Thomas E. Stinchcombe, Neal E. Ready, and Harvey J. Cohen, Duke University 
      Medical Center; Xiaofei Wang, Alliance Statistics and Data Center, Durham, NC; 
      Ying Zhang, Pennsylvania State University College of Medicine, Hershey, PA; 
      Everett E. Vokes, University of Chicago Medical Center, Chicago, IL; Joan H. 
      Schiller, Inova Dwight and Martha Schar Cancer Institute, Falls Church, VA; 
      Jeffrey D. Bradley and Ramaswamy Govindan, Washington University School of 
      Medicine, St Louis, MO; Karen Kelly, University of California Davis, Sacramento, 
      CA; Walter J. Curran Jr, Winship Cancer Institute of Emory University, Atlanta, 
      GA; Steven E. Schild, Mayo Clinic Arizona, Scottsdale, AZ; Benjamin Movsas, Henry 
      Ford Health System, Detroit, MI; Gerald Clamon, University of Iowa Hospital and 
      Clinics, Iowa City, IA; George R. Blumenschein, University of Texas MD Anderson 
      Cancer Center, Houston, TX; Mark A. Socinski, Florida Hospital Cancer Institute, 
      Orlando, FL; Wallace L. Akerley, Huntsman Cancer Institute, University of Utah, 
      Salt Lake City, UT; and Herbert H. Pang, University of Hong Kong, Hong Kong 
      Special Administrative Region, People's Republic of China.
LA  - eng
GR  - P01 CA142538/CA/NCI NIH HHS/United States
GR  - R21 AG042894/AG/NIA NIH HHS/United States
GR  - U10 CA180833/CA/NCI NIH HHS/United States
GR  - U10 CA180888/CA/NCI NIH HHS/United States
PT  - Journal Article
DEP - 20170511
PL  - United States
TA  - J Clin Oncol
JT  - Journal of clinical oncology : official journal of the American Society of 
      Clinical Oncology
JID - 8309333
SB  - IM
CIN - J Clin Oncol. 2017 Sep 1;35(25):2860-2862. PMID: 28537813
MH  - Age Factors
MH  - Aged
MH  - Carcinoma, Non-Small-Cell Lung/*drug therapy/pathology/*radiotherapy
MH  - Chemoradiotherapy
MH  - Clinical Trials, Phase II as Topic
MH  - Clinical Trials, Phase III as Topic
MH  - Female
MH  - Humans
MH  - Lung Neoplasms/*drug therapy/pathology/*radiotherapy
MH  - Male
MH  - Neoplasm Staging
MH  - Randomized Controlled Trials as Topic
PMC - PMC5578390
EDAT- 2017/05/12 06:00
MHDA- 2017/09/16 06:00
PMCR- 2018/09/01
CRDT- 2017/05/12 06:00
PHST- 2017/05/12 06:00 [pubmed]
PHST- 2017/09/16 06:00 [medline]
PHST- 2017/05/12 06:00 [entrez]
PHST- 2018/09/01 00:00 [pmc-release]
AID - 714758 [pii]
AID - 10.1200/JCO.2016.71.4758 [doi]
PST - ppublish
SO  - J Clin Oncol. 2017 Sep 1;35(25):2885-2892. doi: 10.1200/JCO.2016.71.4758. Epub 
      2017 May 11.